US Olympic boxer Virginia Fuchs escapes ban after claiming failed drugs test caused by sex

The flyweight's sample from an out-of-competition test in February flagged two of Wada's banned substances 

Jack Rathborn
Friday 12 June 2020 08:20
Comments
Virginia Fuchs has been cleared of a positive drugs test
Virginia Fuchs has been cleared of a positive drugs test

U.S. Olympic boxer Virginia Fuchs has had a failed drugs test cleared after blaming it on having sex with her boyfriend.

The United States Anti-Doping Agency (Usada) determined that her sample, which contained two banned substances (letrozole metabolite and GW1516 metabolites), was transmitted through intercourse.

The 32-year-old flyweight’s sample, which contravenes World Anti-Doping Agency (Wada) rules on banned substances, was taken at an out-of-competition urine test on 13 February.

“The low amounts of letrozole metabolite and GW1516 metabolites detected in her sample were consistent with recent exposure to the substances via sexual transmission,” the USADA said it had determined in its investigation.

The anti-doping body said Fuchs’s partner had been using therapeutic doses of the two substances and that Fuchs bore no fault or negligence for the adverse finding and would therefore not be banned.

“We strongly believe this case and others like it, including meat contamination and prescription medication contamination cases should be considered no violation,” USADA chief Travis Tygart said.

Fuchs narrowly missed out on qualifying for the Rio Olympics in 2016 and has now set her sights on next year’s delayed Tokyo Games.

“This has been a huge lesson for me and now that is over, I’m fully focused on preparing for Tokyo,” she wrote on Twitter.

The usual punishment for the use of banned substances is a four-year ban from all WADA-compliant sports.

In 2017, USADA allowed middle-distance runner Ajee Wilson off without a suspension, concluding that traces of an anabolic agent in her sample had come from contaminated beef.

Reuters also contributed to this report

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in